# FDA Inspection 1168196 - Octapharma Plasma, Inc. - April 21, 2022

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/1838689c-536a-4e1a-93d3-b9169e2990b1
Source feed: FDA_Inspections

> FDA Inspection 1168196 for Octapharma Plasma, Inc. on April 21, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1168196
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2022-04-21
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1168196 - 2022-04-21](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/299a2bb1-bde2-433a-9b2d-1b0f96f4153e)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/8510dc19-b77c-467d-a3a8-6813be9dbfbf

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d